Search

everythinglearnresearchcommunity

for

Search:↓

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Increasing sleep by 41 minutes daily for a month showed no significant changes in metabolism or hormone levels in healthy women.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Aromatase inhibitors cause male pattern hair loss in women.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Sunekos® effectively improves labia majora appearance and is well-tolerated.

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.

Low iron levels are linked to hair loss in women.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

The supplement reduces hair loss and increases hair thickness in older women.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Hormonal status significantly affects women's skin health throughout their lives.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.